Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akito Hata

Showing results (51-60 of 146) with videos related to

Pageof 15
Sort By:
Plos One|June 16, 2015
Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung CancerShiro Fujita, Katsuhiro Masago, Jumpei Takeshita, et al.
Pathology International|January 18, 2018
Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancerKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Cancer Medicine|January 10, 2024
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancerAkito Hata, Simon Fifer, Kazuo Hasegawa, et al.
JTO Clinical and Research Reports|January 1, 2024
Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational StudyYuki Sato, Satoru Fujiwara, Akito Hata, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 30, 2009
[A case of lung cancer combined with pregnancy; dramatically deteriorating condition after caesarian section]Akito Hata, Yuka Harada, Ryutaro Seo, et al.
British Journal of Cancer|December 1, 2017
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancerShigeki Nanjo, Akito Hata, Chiyuki Okuda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 12, 2010
Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancerMiyako Satouchi, Yoshikazu Kotani, Nobuyuki Katakami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 25, 2014
[Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia]Akito Hata, Nobuyuki Katakami, Yoshio Masuda, et al.
BMC Medical Genetics|December 1, 2010
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapyShiro Fujita, Katsuhiro Masago, Yukimasa Hatachi, et al.
Anticancer Research|May 13, 2015
A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapyJumpei Takeshita, Katsuhiro Masago, Ryoji Kato, et al.
Pageof 15

Showing results (51-60 of 146) with videos related to

Sort By:
Pageof 15
Plos One|June 16, 2015
Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung CancerShiro Fujita, Katsuhiro Masago, Jumpei Takeshita, et al.
Pathology International|January 18, 2018
Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancerKatsuhiro Masago, Shiro Fujita, Akito Hata, et al.
Cancer Medicine|January 10, 2024
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancerAkito Hata, Simon Fifer, Kazuo Hasegawa, et al.
JTO Clinical and Research Reports|January 1, 2024
Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational StudyYuki Sato, Satoru Fujiwara, Akito Hata, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 30, 2009
[A case of lung cancer combined with pregnancy; dramatically deteriorating condition after caesarian section]Akito Hata, Yuka Harada, Ryutaro Seo, et al.
British Journal of Cancer|December 1, 2017
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancerShigeki Nanjo, Akito Hata, Chiyuki Okuda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 12, 2010
Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancerMiyako Satouchi, Yoshikazu Kotani, Nobuyuki Katakami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 25, 2014
[Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia]Akito Hata, Nobuyuki Katakami, Yoshio Masuda, et al.
BMC Medical Genetics|December 1, 2010
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapyShiro Fujita, Katsuhiro Masago, Yukimasa Hatachi, et al.
Anticancer Research|May 13, 2015
A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapyJumpei Takeshita, Katsuhiro Masago, Ryoji Kato, et al.
Pageof 15